battery expansion

$135 million in funding secured for new Houston battery storage facility

SMT Energy is expected to bring a new battery storage facility online next year to support the ERCOT grid. Photo via Getty Images

Boulder, Colorado-based SMT Energy has secured $135 million in funding for a 160-megawatt battery energy storage facility, dubbed SMT Houston IV, according to an announcement.

The new facility will work to support the ERCOT grid by providing access to stored energy. The project is expected to be online by 2026 and store and dispatch enough electricity to power 8,800 homes in Texas annually.

Macquarie and KeyBanc Capital Markets were joint lead arrangers in a $100 million project financing facility. Macquarie's Commodities and Global Markets business will also provide a preferred equity investment and are mandated to sell the project's investment tax credits of approximately $62 million, according to SMT. KeyBanc will also act as a financial advisor to SMT.

North Carolina-based battery energy storage integrator FlexGen Power Systems will obtain equipment for the project. The project will also use FlexGen's energy management system software. The software provides site integration, site control and advanced analytics insights to maximize the availability and operating ranges of battery energy storage assets.

"FlexGen is proud to partner with SMT Energy on the deployment of the SMT Houston IV project, which will deliver critical services to the dynamic ERCOT power grid," Jason Abiecunas, Executive Vice President of Business Development with FlexGen said in the release.

In 2023, SMT Energy and joint venture partner SUSI Partners announced plans to add 10 battery storage projects to Texas, doubling capacity from 100 megawatts to 200 megawatts in the Houston and Dallas areas. SMT has a 2 gigawatt per hour pipeline of battery energy storage projects in ERCOT and Southwest Power Pool targeted for commercial operation by 2030, according to the release.

Trending News

A View From HETI

Cemvita has named a new leader in Brazil. Photo via cemvita.com

Houston industrial biotech company Cemvita has announced two strategic moves to advance its operations in Brazil.

The company, which utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals, acquired a complementary technology that expands its IP and execution of scale-up capacity, according to a news release. The acquisition will bring additional synthetic biology toolsets that Cemvita believes will assist with compressing and commercializing timelines.

The company also appointed Luciano Zamberlan as vice president of operations based in Brazil.

Zamberlan will lead operational execution, site readiness and early commissioning activities in Brazil. He brings more than 20 years of experience in biotechnology to the role. He recently served as director of engineering at Raízen, Brazil’s largest ethanol producer and the world’s largest producer of sugarcane ethanol. At Raízen, he coordinated the implementation of four greenfield plants and oversaw operational teams and process optimization for second-generation ethanol (E2G) and biogas.

“I am very pleased to join Cemvita, a company at the forefront of transforming waste into valuable, sustainable resources,” Zamberlan said in the release. “My expertise in scaling-up innovation, coupled with my experience in structuring and commissioning greenfield industrial operations, is perfectly aligned with Cemvita's mission and I'm eager to bring my energy and drive to accelerate Cemvita's industrial performance and contribute for a circular future.”

Cemvita expanded to Brazil in January to help capitalize on the country’s progressive regulatory framework, including Brazil’s Fuel of the Future Law, enacted in 2024. The law mandates an increase in the biodiesel content of diesel fuel, starting from 15 percent in March and increasing to 20 percent by 2030. It also requires the adoption of Sustainable Aviation Fuel (SAF) and for domestic flights to reduce greenhouse gas emissions by 1 percent starting in 2027, growing to 10 percent reduction by 2037.

“These steps enable us to augment Brazil’s longstanding bioindustrial ecosystem with next-generation capabilities, reducing early commercialization risk and expanding optionality for future product platforms,” Marcio Silva, CTO of Cemvita, said in the news release. “Together, they strengthen our ability to move from proof-of-concept to industrial reality.”

Trending News